MicroRNA-92b represses invasion-metastasis cascade of esophageal squamous cell carcinoma

Oncotarget

Volumn 7, Issue 15, 2016, Pages 20209-20222

  Ma, Gang ^a   Jing, Chao ^a   Li, Lin ^a   Huang, Furong ^a   Ding, Fang ^a   Wang, Baona ^a   Lin, Dongmei ^a   Luo, Aiping ^a   Liu, Zhihua ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Esophageal cancer; Integrin V; Invasion; Metastasis; MicroRNA 92b

Indexed keywords

CD51 ANTIGEN; FOCAL ADHESION KINASE; MICRORNA; MICRORNA 92B; RAC1 PROTEIN; UNCLASSIFIED DRUG; FOCAL ADHESION KINASE 1; MIRN92 MICRORNA, HUMAN; PTK2 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; ITAGAV GENE; METASTASIS INHIBITION; MOUSE; NONHUMAN; RNA ANALYSIS; SQUAMOUS CELL CARCINOMA CELL LINE; UPREGULATION; ANIMAL; APOPTOSIS; CELL PROLIFERATION; DRUG SCREENING; ESOPHAGUS TUMOR; GENETICS; HUMAN; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; SECONDARY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE; TUMOR INVASION;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHAV; LYMPHATIC METASTASIS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; RAC1 GTP-BINDING PROTEIN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84964725800     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7747     Document Type: Article

References (43)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015; 65:87-108.
2. Rustgi AK and El-Serag HB. Esophageal carcinoma. The New England journal of medicine. 2014; 371:2499-2509.
3. Pennathur A, Gibson MK, Jobe BA and Luketich JD. Oesophageal carcinoma. Lancet. 2013; 381:400-412.
4. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144:646-674.
5. Wan L, Pantel K and Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nature medicine. 2013; 19:1450-1464.
6. Brabletz T, Lyden D, Steeg PS and Werb Z. Roadblocks to translational advances on metastasis research. Nature medicine. 2013; 19:1104-1109.
7. Roussos ET, Condeelis JS and Patsialou A. Chemotaxis in cancer. Nature reviews Cancer. 2011; 11:573-587.
8. Friedl P and Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell. 2011; 147:992-1009.
9. Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, Ma X, Liu L, Zhao Z, Huang X, Fan J, Dong L, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014; 509:91-95.
10. Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, Zhang F, Zhao ZR, Li ZT, Liu ZY, Zhao YD, Sun J, Zhou CC, Yao R, Wang SY, Wang P, et al. Genetic landscape of esophageal squamous cell carcinoma. Nature genetics. 2014; 46:1097-1102.
11. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, Garg M, Liu LZ, Yang H, Yin D, Shi ZZ, Jiang YY, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nature genetics. 2014; 46:467-473.
12. Chiang AC and Massague J. Molecular basis of metastasis. The New England journal of medicine. 2008; 359:2814-2823.
13. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nature Cell Biology. 2013; 15:546-54.
14. Ma L, Teruya-Feldstein J and Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449:682-688.
15. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL and Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008; 451:147-152.
16. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, Yen Y, Wang Y, Marcusson EG, Chu P, Wu J, Wu X, et al. Cancersecreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer cell. 2014; 25:501-515.
17. Tetreault MP, Wang ML, Yang Y, Travis J, Yu QC, Klein-Szanto AJ and Katz JP. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology. 2010; 139:2124-2134 e2129.
18. Tetreault MP, Yang Y, Travis J, Yu QC, Klein-Szanto A, Tobias JW and Katz JP. Esophageal squamous cell dysplasia and delayed differentiation with deletion of kruppel-like factor 4 in murine esophagus. Gastroenterology. 2010; 139:171-181 e179.1
19. Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H and Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. The Journal of biological chemistry. 2010; 285:7986-7994.
20. Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S and Wang Y. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neurooncology. 2013; 15:578-588.
21. Li Y, Li L, Guan Y, Liu X, Meng Q and Guo Q. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. Biochemical and biophysical research communications. 2013; 440:604-610.
22. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y and Fan D. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS genetics. 2010; 6:e1000879.
23. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E and Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature cell biology. 2008; 10:202-210.
24. Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY and Korean ESDSG. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clinical endoscopy. 2014; 47:523-529.
25. Shibue T and Weinberg RA. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Seminars in cancer biology. 2011; 21:99-106.
26. Sulzmaier FJ, Jean C and Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nature reviews Cancer. 2014; 14:598-610.
27. Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK and Cheresh DA. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer research. 2009; 69:1383-1391.
28. Desgrosellier JS and Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nature reviews Cancer. 2010; 10:9-22.
29. Nowakowski TJ, Fotaki V, Pollock A, Sun T, Pratt T and Price DJ. MicroRNA-92b regulates the development of intermediate cortical progenitors in embryonic mouse brain. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110:7056-7061.
30. Zhou X, Zhu W, Li H, Wen W, Cheng W, Wang F, Wu Y, Qi L, Fan Y, Chen Y, Ding Y, Xu J, Qian J, Huang Z, Wang T, Zhu D, et al. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Scientific reports. 2015; 5:11251.
31. Pal S, Baiocchi RA, Byrd JC, Grever MR, Jacob ST and Sif S. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. The EMBO journal. 2007; 26:3558-3569.
32. Vidigal JA and Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends in cell biology. 2015; 25:137-147.
33. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002; 110:673-687.
34. Seguin L, Desgrosellier JS, Weis SM and Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends in cell biology. 2015; 25:234-240.
35. Reymond N, d'Agua BB and Ridley AJ. Crossing the endothelial barrier during metastasis. Nature reviews Cancer. 2013; 13:858-870.
36. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ and Bishop JM. MYC suppresses cancer metastasis by direct transcriptional silencing of av and β3 integrin subunits. Nature Cell Biology.2012;14:567-574.
37. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC and van der Pluijm G. Integrin av expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. American Journal of Pathology.2011;179:2559-2568.
38. Guo W and Giancotti FG. Integrin signalling during tumour progression. Nature reviews Molecular cell biology. 2004; 5:816-826.
39. Shimada Y, Imamura M, Wagata T, Yamaguchi N and Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer. 1992; 69:277-284.
40. Akbar H, Cancelas J, Williams DA, Zheng J and Zheng Y. Rational design and applications of a Rac GTPase-specific small molecule inhibitor. Methods in enzymology. 2006; 406:554-565.
41. Tiscornia G, Singer O and Verma IM. Production and purification of lentiviral vectors. Nature protocols. 2006; 1:241-245.
42. Gros SJ, Dohrmann T, Peldschus K, Schurr PG, Kaifi JT, Kalinina T, Reichelt U, Mann O, Strate TG, Adam G, Hoffman RM and Izbicki JR. Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model. International journal of cancer Journal international du cancer. 2010; 126:2671-2681.
43. Xu C, Chen H, Wang X, Gao J, Che Y, Li Y, Ding F, Luo A, Zhang S and Liu Z. S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling. The Journal of biological chemistry. 2014; 289:827-837.